Tobacco Asia

Volume-27 - Number-5

Issue link: https://read.dmtmag.com/i/1506051

Contents of this Issue

Navigation

Page 33 of 83

34 tobaccoasia Issue 5, 2023 September / October Ideal for EU vapers dissatisfied with 20mg/ml limits PATENTED FORMULA available exclusively from Alchem The perfect hit for difficult- to-convert smokers A novel nicotine base engineered for a faster stronger delivery of nicotine Sponsored Post In late 2022, we started field testing with the pat- ented NicSelect T-Max formula developed by Natural Academy, the University of Milan Bicocca, and Alchem NicSelect. This was the first time that Alchem NicSelect had developed a product with these research partners, and it was fascinating to see what had been created and if we had a game- changer. Straight out of the box, the reaction was off the scale! So, what is T-Max? Well, put simply, T-Max is a novel nicotine base, a clever, patented for- mulation that exploits the specific properties of ingredients already commonly used in the vaping industry. And what exactly does T-Max do? T- Max optimizes the speed of delivery of nicotine and the nicotine hit without increasing the nico- tine dosage; and remarkably, it can also do this with a reduced nicotine dosage. NicSelect T-Max is also fully compliant with European TPD legis- lation, which means that it is suitable for vaping worldwide. "Vapes just like a cigarette" is important and a game-changer. According to the scientific litera- ture, the most frequent reason for vapers to re- turn to traditional smoking lies in an unsatisfying perception of the nicotine hit; the hit is defined as the speed at which nicotine activates the recep- tors and the perceived strength of the hit. Tradi- tionally, smokers have learned to associate the act of smoking a traditional cigarette with an almost immediate physical perception of nicotine, a per- ception which, with the classic electronic cigarette, nicotine bases, or nicotine salts, is delayed and less satisfactory. The 20 mg/ml limit defined by the EU TPD-II is restrictive and can lead to low satisfaction among traditional smokers trying to switch to e-cigarettes or encourage the use of non- compliant products with nicotine levels well above the EU TPD-II and potentially harmful to health. NicSelect T-Max is formulated within the nicotine dosage limits set by the EU TPD-II (at 20mg/ml maximum); it activates the nicotine re- The T-Max Effect: It Vapes Just Like a Cigarette by Anna Balconi, Technical Manager at Alchem NicSelect. NicSelect T-Max, a game-changing product and revolutionary technology that is more efficient than traditional nicotine bases and salts, while complying with the European Tobacco Products Directive (EU TPD).

Articles in this issue

Archives of this issue

view archives of Tobacco Asia - Volume-27 - Number-5